Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CRISPR Therapeutics AG
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Market Capitalisation
$5.00B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.3M
High today
$55.99
Low today
$51.15
Open price
$55.99
52-week high
$78.48
52-week low
$37.02
Ready to start your investing journey with Stake?
Open an accountHow do I buy CRSP shares in Australia?
Buying CRSP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CRISPR Therapeutics AG in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRSP
What is the ticker symbol of CRISPR Therapeutics AG?
The ticker symbol for CRISPR Therapeutics AG is CRSP.
How much is one share of CRSP?
One share of CRSP is valued at $52.07 as of 06 June 2026.
What is the market capitalisation of CRISPR Therapeutics AG CRSP?
As of 06 June 2026 CRISPR Therapeutics AG has a market cap of $5.00B.
What is the 52-week high for CRISPR Therapeutics AG stock?
The CRISPR Therapeutics AG 52-week high stock price is $78.48.
What is the 52-week low for CRISPR Therapeutics AG stock?
The CRISPR Therapeutics AG 52-week low stock price is $37.02.
Can I buy CRSP shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy CRSP shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRSP on Stake
- Buy CRSP from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CRSP from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CRSP related stocks